International Symposium on Advances in Synthetic and Medicinal Chemistry
ASMC07 in St. Petersburg is being prepared by EFMC (European Federation for Medicinal Chemistry) and ChemBridge Corporation with the support of ACS and ACS Division of Medicinal Chemistry, in the series of events which started with ASCMC04 in Moscow.Out of the submitted abstract the Scientific Committee will chose 10
The scientific program of the International Symposium on Advances in Synthetic and Medicinal Chemistry will encompass:
- 14 plenary lectures, presented by leading scientists from Europe, USA and Russia
- 15 invited major talks, presented primarily by highly recognized scientists from the pharmaceutical and biotech industry, as well as from academia
- 10 short oral communications which will be selected from submitted abstracts
- poster sessions
The scientific program will be complemented by an attractive cultural program in St. Petersburg.
The topics to be covered during this symposium include:
- New Synthetic Methodologies, Total Synthesis of Natural Products and Heterocyclic Chemistry
- Diversity- and Target-Oriented Synthesis and Chemical Biology
- Medicinal Chemistry and Drug Discovery & Development
The program will also include a commercial exhibition and a half-day Business Mini-Symposium “Discovery Chemistry Outsourcing Opportunities in Russia”.
| Confirmed Plenary Speakers | |
| Dr. Magid ABOU-GHARBIA (WYETH RESEARCH, Princeton, United States) |
|
| Prof. Irina P. BELETSKAYA (MOSCOW STATE UNIVERSITY, MOSCOW, Russia) |
|
| Prof. Scott BILLER (NOVARTIS, Cambridge, United States) |
|
| Prof. Erick M. CARREIRA (ETH ZURICH, Zürich, Switzerland) |
|
| Prof. Gregory C. FU (MASSACHUSETTS INSTITUTE OF TECHNOLOGY, Cambridge, United States) |
|
| Dr. William J. GREENLEE (SCHERING-PLOUGH RESEARCH INSTITUTE, Kenilworth, United States) |
|
| Prof. Robert H. GRUBBS (CALIFORNIA INSTITUTE OF TECHNOLOGY, Pasadena, United States) |
|
| Prof. Laura KIESSLING (UNIVERSITY OF WISCONSIN, Madison, United States) |
|
| Prof. Paul KNOCHEL (LUDWIG MAXIMILIANS UNIVERSITY, Munchen, Germany) |
|
| Prof. Steven V. LEY (UNIVERSITY OF CAMBRIDGE, Cambridge, United Kingdom) |
|
| Prof. Larry E. OVERMAN (UNIVERSITY OF CALIFORNIA, Irvine, United States) |
|
| Prof. Roberto PELLICCIARI (UNIVERSITY OF PERUGIA, Perugia, Italy) |
|
| Prof. Ron RAINES (UNIVERSITY OF WISCONSIN, Madison, United States) |
|
| Prof. Julius REBEK (SCRIPPS RESEARCH INSTITUTE, La Jolla, United States) |
|
| Confirmed Major Talks (to Date) | |
| Dr. Balu BALASUBRAMANIAN (BRYSTOL-MYERS SQUIBB, Princeton, United States) |
|
| Prof. Maurizio BOTTA (UNIVERSITY OF SIENA, Siena, Italy) |
|
| Dr. John ELLINGBOE (WYETH RESEARCH, Pearl River, United States) |
|
| Dr. Dan FLYNN (DECIPHERA PHARAMCEUTICALS, Lawrence, United States) |
|
| Dr. Jörg HUESER (BAYER SCHERING PHARMA, Wuppertal, Germany) |
|
| Dr. Wilson KNIGHT (GSK, Research Triangle Park, United States) |
|
| Dr. Paul LEESON (ASTRAZENECA, Leics, United Kingdom) |
|
| Dr. Peter NUSSBAUMER (NOVARTIS FORSCHUNGSINSTITUT, Vienna, Austria) |
|
| Dr. Hamish RYDER (ALMIRALL, Barcelona, Spain) |
|
| Dr. Hans-Ulrich STILZ (Sanofi-Aventis Deutschland GmbH, Frankfurt/Main, Germany) |
|
| Dr. Joe VACCA (MERCK & Co., WEST POINT, United States) |
|
| Dr. Tanja WEIL (MERZ PHARMACEUTICALS, Frankfurt/Main, Germany) |
|
| Dr. Anthony WOOD (PFIZER, Sandwich, United Kingdom) |
|
| Confirmed Business Mini Symposium Speakers and Panel Participants (to Date) | |
| Dr. Balu BALASUBRAMANIAN (BRYSTOL-MYERS SQUIBB, Princeton, United States) |
|
| Dr. Michael CLARK (PFIZER, New London, United States) |
|
| Dr. Richard D. CONNELL (PFIZER, Groton, United States) |
|
| Dr Frederik DEROOSE (JOHNSON & JOHNSON PHARMACEUTICALS, BEERSE, Belgium) |
|
| Mr Steven HUTCHINS (MERCK & Co., RAHWAY, United States) |
|
| Dr. Wilson KNIGHT (GSK, Research Triangle Park, United States) |
|
| Dr. Garry PAIRAUDEAU (ASTRAZENECA R&D Charnwood, Loughborough, United Kingdom) |
|
| Mr. Eugene VAISBERG (CHEMBRIDGE CORPORATION, SAN DIEGO, United States) |
|
